First, by blocking phosphorylation of Ser2-RNAPII, CDKI-73 inhibits transcription and reduces levels of key cancer-promoting factors such as MYC, pro-survival members of the BCL-2 family, and AR. The gene discussed is AR; the disease is cancer.